{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:05:13Z","timestamp":1759190713282,"version":"3.44.0"},"reference-count":14,"publisher":"European Respiratory Society (ERS)","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2025,4,27]]},"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1183\/23120541.00421-2025","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T07:50:21Z","timestamp":1759132221000},"page":"00421-2025","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["<i>Aspergillus<\/i> and <i>Pseudomonas<\/i> lung infections: that's what friends are spore"],"prefix":"10.1183","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0374-3611","authenticated-orcid":false,"given":"Dominic","family":"Hughes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3902-6502","authenticated-orcid":false,"given":"Freddy","family":"Frost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2025,9,28]]},"reference":[{"key":"2025092900501366000_11.5.00421-2025.1","unstructured":"Cystic Fibrosis Trust . UK Cystic Fibrosis Registry: 2023 Annual Data Report. London, Cystic Fibrosis Trust, 2024. https:\/\/www.cysticfibrosis.org.uk\/sites\/default\/files\/2024-11\/CFT_2023_Annual_Data_Report_Oct2024%201.pdf"},{"key":"2025092900501366000_11.5.00421-2025.2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(23)00093-0"},{"key":"2025092900501366000_11.5.00421-2025.3","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1513\/AnnalsATS.201902-122OC","article-title":"Ivacaftor is associated with reduced lung infection by key cystic fibrosis pathogens. A cohort study using national registry data","volume":"16","author":"Frost","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"2025092900501366000_11.5.00421-2025.4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu944"},{"key":"2025092900501366000_11.5.00421-2025.5","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jcf.2022.09.007","article-title":"Advent of elexacaftor\/tezacaftor\/ivacaftor for cystic fibrosis treatment: what consequences on Aspergillus-related diseases? Preliminary insights","volume":"21","author":"Chesnay","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2025092900501366000_11.5.00421-2025.6","doi-asserted-by":"crossref","first-page":"01035","DOI":"10.1183\/23120541.01035-2024","article-title":"Aspergillus \n               fumigatus is influenced by mucus accumulation, airway inflammation and cystic fibrosis transmembrane conductance regulator function","volume":"11","author":"Poore","year":"2025","journal-title":"ERJ Open Res"},{"key":"2025092900501366000_11.5.00421-2025.7","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.2.839"},{"key":"2025092900501366000_11.5.00421-2025.8","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myaa066"},{"key":"2025092900501366000_11.5.00421-2025.9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134692"},{"key":"2025092900501366000_11.5.00421-2025.10","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00345-17"},{"key":"2025092900501366000_11.5.00421-2025.11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jcf.2022.07.009","article-title":"An invisible threat? Aspergillus positive cultures and co-infecting bacteria in airway samples","volume":"22","author":"Hughes","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2025092900501366000_11.5.00421-2025.12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-7-45"},{"key":"2025092900501366000_11.5.00421-2025.13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202108-1986OC"},{"key":"2025092900501366000_11.5.00421-2025.14","doi-asserted-by":"crossref","first-page":"e01516\u201323","DOI":"10.1128\/mbio.01516-23","article-title":"The cystic fibrosis treatment Trikafta affects the growth, viability, and cell wall of Aspergillus fumigatus biofilms","volume":"14","author":"Jones","year":"2023","journal-title":"mBio"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00421-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T07:50:23Z","timestamp":1759132223000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00421-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":14,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,9,28]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1183\/23120541.00421-2025"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00421-2025","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}